JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 9.58% |
| 3 | Consumer Discretionary | 9.07% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
3901
DELISTED
Faro Technologies
FARO
| $1.47M | ﹤0.01% |
68,473
-7,185
| -9% | -$156K |
|
3902
Phathom Pharmaceuticals
PHAT
$775M
| $1.47M | ﹤0.01% |
138,452
-7,585
| -5% | -$64.4K |
|
3903
Mid Penn Bancorp
MPB
$974M
| $1.46M | ﹤0.01% |
73,182
+2,910
| +4% | +$62.7K |
|
|
TRST
3904
Trustco Bank Corp NY
TRST
$977M
| $1.46M | ﹤0.01% |
51,877
+5,001
| +11% | +$142K |
|
3905
Lyell Immunopharma
LYEL
$342M
| $1.46M | ﹤0.01% |
32,731
+24,601
| +303% | +$1.05M |
|
3906
Embecta
EMBC
$289M
| $1.45M | ﹤0.01% |
109,485
+32,944
| +43% | +$510K |
|
3907
Sierra Bancorp
BSRR
$532M
| $1.45M | ﹤0.01% |
71,885
+8,965
| +14% | +$177K |
|
3908
CALL
BridgeBio Pharma
BBIO
$15.6B
| $1.45M | ﹤0.01% |
46,900
+29,000
| +162% | +$986K |
|
3909
Global X SuperDividend ETF
SDIV
$1.21B
| $1.45M | ﹤0.01% |
66,885
+915
| +1% | +$19.7K |
|
|
ADAP
3910
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.45M | ﹤0.01% |
915,030
-13,194
| -1% | -$15.9K |
|
3911
Overlay Shares Short Term Bond ETF
OVT
$61.6M
| $1.44M | ﹤0.01% |
64,673
+36,633
| +131% | +$805K |
|
3912
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
| $1.44M | ﹤0.01% |
27,978
-1,423
| -5% | -$72.9K |
|
3913
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
| $1.44M | ﹤0.01% |
58,837
+21,663
| +58% | +$529K |
|
3914
Harmony Biosciences
HRMY
$2.22B
| $1.44M | ﹤0.01% |
42,839
-80,065
| -65% | -$2.57M |
|
|
MORF
3915
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.44M | ﹤0.01% |
40,781
-19,566
| -32% | -$656K |
|
3916
PUT
JB Hunt Transport Services
JBHT
$26.3B
| $1.43M | ﹤0.01% |
7,200
| – | – |
|
3917
FerroAtlántica
GSM
$820M
| $1.43M | ﹤0.01% |
287,743
+142,836
| +99% | +$737K |
|
3918
PUT
Corning
GLW
$143B
| $1.43M | ﹤0.01% |
43,400
-171,800
| -80% | -$5.47M |
|
3919
GraniteShares Gold Shares
BAR
$1.47B
| $1.43M | ﹤0.01% |
65,001
-2,750
| -4% | -$56.3K |
|
|
EDN
3920
Edenor
EDN
$1.01B
| $1.43M | ﹤0.01% |
80,654
+4,165
| +5% | +$75.1K |
|
3921
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$697M
| $1.43M | ﹤0.01% |
25,550
+4,585
| +22% | +$254K |
|
3922
Alta Equipment Group
ALTG
$237M
| $1.42M | ﹤0.01% |
109,850
+89,551
| +441% | +$1.03M |
|
3923
Bar Harbor Bankshares
BHB
$681M
| $1.42M | ﹤0.01% |
53,713
+9,486
| +21% | +$247K |
|
3924
Dimensional Emerging Markets Value ETF
DFEV
$2.1B
| $1.42M | ﹤0.01% |
54,582
+4,908
| +10% | +$123K |
|
3925
Comstock Resources
CRK
$4.13B
| $1.41M | ﹤0.01% |
152,344
-257,759
| -63% | -$2.12M |
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $43.6B of net new capital in Q1 2024, opening 625 new positions and adding to 3,258 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 766 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.